Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Metabolomics analysis identifies metabolites associated with systemic acquired resistance in Arabidopsis
- Essential omega-3 fatty acids tune microglial phagocytosis of synaptic elements in the developing brain
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
- Microbial Diversity and Non-volatile Metabolites Profile of Low-Temperature Sausage Stored at Room Temperature
- Lipid mediators of inflammation in BALF 3-19 days after infection with influenza.
- Lipid mediators of inflammation in BALF 6-19 days after infection with influenza.
- Lipid mediators of inflammation in BALF 3-11 days after infection with influenza.
- Lipid mediators of inflammation in BALF 3-13 days after infection with influenza.
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
- Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
- Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
- Flow cytometry has a significant impact on the cellular metabolome (General LC-MS assay)
- PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
- TGF-β uncouples glycolysis and inflammation in macrophages and controls the survival during sepsis
- Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
Observed in differential profiles
- Local_Leaf_Control_vs_Local_Leaf_Avr
- n-3_PUFA_sufficient_vs_n-3_PUFA_deficient
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- Control_vs_AONFH_Stage_III_IV
- Control_vs_Day_12
- Mock_18_days_vs_X31_19_days
- Mock_19d_vs_PR8_19d
- G1_Mock_11_day_vs_G5_PR8_11_day
- Mock_13d_vs_PR8_13d
- G1_PBS_vs_G2_DSS
- Control_vs_CSD
- Control_vs_ZYP_High_Dose
- Male_19_days_vs_Male_1_day
- Ctrl_vs_Ab
- wild_type_vs_patA_deletion
- Control_vs_TGF-beta_Treatment
- Control_vs_BP3_Low_Concentration